Answers are grounded in this paper and cite their sources.
MNA®-result predicts mortality/survival, cancer progression, treatment maintenance and (health-related) quality of life and did not predict adverse treatment outcomes and functional status/ decline in patients with cancer. For other outcomes results are less clear. The moderate to high RoB calls for studies with better control of potential confounders.
No takes yet. Share an insight, caveat, or question.
Torbahn et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: